来自MSN1 个月
First of its kind drug significantly reduces heart attacks and strokes
Unlike other inhibitors that primarily block SGLT2, this drug targets both SGLT1 and SGLT2 proteins. These proteins help regulate glucose and sodium movement in the body, influencing blood sugar ...
来自MSN1 个月
Research shows sotagliflozin is the first medication of its kind to significantly reduce ...
Sotagliflozin, a drug recently approved by the Food and Drug ... It blocks the function of two proteins, known as SGLT1 and SGLT2, which move glucose and sodium across cell membranes and help ...